🔎 Trials Near Me

Akèy › Maladi Greff-versus-host › Illinois

Etid klinik pou Maladi Greff-versus-host nan Illinois

3 etid pou Maladi Greff-versus-host ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • The University of Chicago Medical Center (UCMC), Chicago
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT04710576

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

  • University of Chicago, Chicago
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT04380740

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • University of Illinois Medical Center - Hematology & Oncology, Chicago
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.